Meifang Wu Selected Research

Meifang Wu Research Topics

Disease

6	Heart Failure 11/2023 - 12/2019
4	Fibrosis (Cirrhosis) 01/2021 - 01/2015
3	ST Elevation Myocardial Infarction 12/2022 - 01/2021
3	Myocarditis (Carditis) 07/2018 - 03/2016
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2013 - 02/2009
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2015
2	Hypertrophy 01/2021 - 01/2021
2	Thrombosis (Thrombus) 11/2013 - 02/2009
1	Left Ventricular Dysfunction 11/2023
1	Infections 11/2022
1	Mycoses (Diseases, Fungus) 11/2022
1	Hypoglycemia (Reactive Hypoglycemia) 12/2021
1	Hyperglycemia 12/2021
1	Diabetic Foot 12/2021
1	Myocardial Infarction 01/2021
1	Pathologic Processes 01/2021
1	Secondary Hyperparathyroidism 12/2019
1	Vitamin D Deficiency 12/2019
1	Inflammation (Inflammations) 12/2019
1	Synovial Chondromatosis (Synovial Osteochondromatosis) 11/2019
1	Ankylosing Spondylitis 11/2019
1	Pain (Aches) 11/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Parkinson Disease (Parkinson's Disease) 10/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2015
1	Aortic Coarctation 01/2015

Drug/Important Bio-Agent (IBA)

6	CollagenIBA 01/2021 - 01/2015
4	qishen yiqiIBA 01/2021 - 01/2015
3	CalciumIBA 11/2023 - 12/2019
3	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2022 - 02/2021
2	AntigensIBA 12/2022 - 02/2021
2	pro-brain natriuretic peptide (1-76)IBA 12/2022 - 02/2021
2	CarbohydratesIBA 12/2022 - 02/2021
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2021
2	Valsartan (Vals)FDA Link 01/2022 - 01/2021
2	Tissue Inhibitor of Metalloproteinase-1IBA 04/2017 - 01/2015
2	AntibodiesIBA 11/2013 - 10/2009
1	Natriuretic PeptidesIBA 11/2023
1	Peroxidase (Myeloperoxidase)IBA 11/2022
1	AntioxidantsIBA 11/2022
1	Protoporphyrinogen Oxidase (Protox)IBA 11/2022
1	ChitinasesIBA 11/2022
1	EnzymesIBA 11/2022
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 11/2022
1	Superoxide DismutaseIBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	ButyrylcholinesteraseIBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Sucrose (Saccharose)IBA 01/2022
1	EstersIBA 01/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022
1	AcetylcholinesteraseIBA 01/2022
1	CreatinineIBA 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2021
1	AlbuminsIBA 12/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Collagen Type III (Type III Collagen)IBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2019
1	Vitamin D FDA LinkGeneric 12/2019
1	Antirheumatic Agents (DMARD)IBA 11/2019
1	Etanercept (Enbrel)FDA Link 11/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019
1	hexabromocyclododecaneIBA 01/2016
1	Benzo(a)pyreneIBA 10/2015
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2015
1	Antiphospholipid AntibodiesIBA 11/2013
1	AutoantigensIBA 10/2009
1	Immunoglobulin G (IgG)IBA 10/2009
1	Fibrinolysin FDA Link 10/2009
1	AntithrombinsIBA 02/2009
1	Factor X (Stuart Factor)IBA 02/2009
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2009
1	Thrombin FDA Link 02/2009
1	AutoantibodiesIBA 02/2009

Therapy/Procedure

4	Therapeutics 11/2023 - 11/2019
2	Patient Readmission 11/2023 - 01/2022
2	Percutaneous Coronary Intervention 01/2022 - 01/2021
2	Duration of Therapy 04/2017 - 01/2015
1	Vagus Nerve Stimulation 11/2023
1	Drug Therapy (Chemotherapy) 11/2023
1	Denervation 11/2023
1	Ligation 01/2021